Care Strategies for Elderly People with Benign Prostatic Hyperplasia: Integrative Literature Review

Main Article Content

Viviane Ferraz Ferreira de Aguiar
Dayara de Nazaré Rosa de Carvalho
Dandara de Fátima Ribeiro Bendelaque
Celice Ruanda Oliveira Sobrinho
Lorena Nayara Alves Neves
Rafael Everton Assunção Ribeiro da Costa
Sara Melissa Lago Sousa
Raylana Tamires Carvalho Contente
Susi dos Santos Barreto de Souza
Juliana Ferreira Rodrigues
Glenda Keyla China Quemel
Fernanda Araújo Trindade
Mônica Custódio do Couto Abreu Pamplona
Antônia Margareth Moita Sá
Ivonete Vieira Pereira Peixoto

Abstract

Objective: The objective of the study is to demonstrate, by means of an Interactive Literature Review, the care strategies for elderly patients with Benign Prostatic Hyperplasia (BPH).

Methodology: An Integrative Literature Review Study (RIL) was carried out, with data collection through online access in the PubMed, Cochrane Library and VHL databases. After evaluation and synthesis of the articles, the data were analyzed in the IraMuTeQ software, presenting the results through the similarity analysis with the identification of co-occurrences between the words and the connection indications.

Results: The research showed that the results of non-invasive and surgical therapies were identified as strategic actions.

Conclusion: It was concluded that care strategies for the elderly with benign prostatic hyperplasia are still scarce, limiting pharmacological and behavioral interventions.

Keywords:
Elderly, care strategies, prostatic hyperplasia.

Article Details

How to Cite
Aguiar, V. F. F. de, Carvalho, D. de N. R. de, Bendelaque, D. de F. R., Sobrinho, C. R. O., Neves, L. N. A., Costa, R. E. A. R. da, Sousa, S. M. L., Contente, R. T. C., Souza, S. dos S. B. de, Rodrigues, J. F., Quemel, G. K. C., Trindade, F. A., Pamplona, M. C. do C. A., Sá, A. M. M., & Peixoto, I. V. P. (2020). Care Strategies for Elderly People with Benign Prostatic Hyperplasia: Integrative Literature Review. Asian Journal of Research and Reports in Urology, 3(1), 15-22. Retrieved from http://journalajrru.com/index.php/AJRRU/article/view/30099
Section
Minireview Article

References

Bortnick EM, Simma-Chiang V, Kaplan AS. Long-term consequences of medical therapy for benign prostatic hyperplasia. Reviews in Urology. 2019;21(4).

Shore N. A review of the prostatic urethral lift for lower urinary tract symptoms: Symptom relief, flow improvement and preservation of sexual function in Men with benign prostatic hyperplasia. Current Bladder Dysfunction Reports. 2015;10(2): 186-192.

Zhang W, Ma L, Bauer BA, Liu Z, Lu Y. et al. Acupuncture for benign prostatic hyperplasia: A systematic review and meta-analysis. PloS One. 2017;12 (4).

Rył A, Rotter I, Miazgowski T, Słojewski M, Dołęgowska B, Lubkowska A, Laszczyńska M. Metabolic syndrome and benign prostatic hyperplasia: Association or coincidence ?. Diabetology & Metabolic Syndrome. 2015;7(94).

Dai X, Fang X, Ma Y, Xianyu J. Benign prostatic hyperplasia and the risk of prostate cancer and bladder cancer: A meta-analysis of observational studies. Medicine. 2016;95(18).

Alawamlh OAH, Goueli R, Lee RK. Lower urinary tract symptoms, benign prostatic hyperplasia and urinary retention. Med Clin North Am. 2018;102(2):301-11.

Cureklibatir I, Kizilay F. Prostate Gland and its Diseases. 1st ed. Bornova, İzmir: Ege University Public Books Series. 2015;18.

Teixeira ID, Sanches AM, Falcão G. A clinical case of low urinary symptoms. See Port Med Geral Fam. 2017;33:134-40.

Barbosa JA, Antunes A. Minimally invasive techniques for the treatment of benign prostatic hyperplasia. Revista De Medicina. 2018;97(3):314-319.

Marchand P, Ratanaud P. L'analyse de similitude appliqueé aux corpus textueles: les primairessocialistes pour l'electionprésidentiellefrançaise. In: Actes des 11eme Journéesinternationalesd' Analysestatistique des DonnéesTextuelles. JADT. 2012;687–699.

Lee HY, Bae GE, Lee SD, Nam JK, Yun YJ, Han JY, Lee DH, Choi JY, Parque SH, Kwon JN. Moxibustion as an adjunct for lower urinary tract symptoms associated with benign prostate enlargement: A randomized controlled pilot trial. Medicine. 2020;99(4).

Park JS, Koo KC, Kim HK, Chung BH, Lee KS. Impact of metabolic syndrome-related factors on the development of benign prostatic hyperplasia and lower urinary tract symptoms in Asian population. Medicine. 2019;98(42).

Wroclawski ML, Carneiro A, Tristão RA, Sakuramoto PK, Youssef JD, Lopes Neto AC, Santiago LH, Pompeo AC. Giant prostatic hyperplasia: report of a previously asymptomatic man presenting with gross hematuria and hypovolemic shock. Einstein. 2016;1-3.

Shih HJ, Huang CJ, Lin JA, Kao MC, Fan YC, Tsai PS. Hyperlipidemia is associated with an increased risk of clinical benign prostatic hyperplasia. The Prostate. 2017; 1-8.

Parsons JK, Sarma AV, McVary K, Wei JT. Obesity and benign prostatic hyperplasia: Clinical connections, emerging etiological paradigms and future directions. The Journal of Urology. 2013;189:102-106.

Kuo YJ, Sung FC, Hsieh PF, Chang HP, Wu KL, Wu HC. Metformin reduces prostate cancer risk among men with benign prostatic hyperplasia: A nationwide population-based cohort study. Cancer Medicine. 2019;1(10).

Santos CMB. Systematization of nursing care for the elderly with benign prostatic hyperplasia: an experience report. In: International Human Development Congress. 2018;6.

Lee YC, Juan YS, Liu CC, Bao BY, Wang CJ, Wu WJ, Huang CN, Huang SP. The association of endothelial nitric oxide synthase (eNOS) G894T gene polymorphism with responsiveness to a selective a1-blocker in men with benign prostatic hyperplasia related lower urinary tract symptoms. BJU Int. 2016;118(2):313-9.

Bitencourt GR, Felippe NHMD, Santana RF. Nursing diagnosis impaired urinary elimination in the elderly in the postoperative period: A cross-sectional study. Rev Enferm UERJ. 2016;24(3): e16629.